Long-term safety of filgrastim (rhG-CSF) administration.
Confer
Dennis L
DL
Miller
John P
JP
D000208:Acute Disease; D000069585:Filgrastim; D016179:Granulocyte Colony-Stimulating Factor / Q000009:adverse effects* / Q000627:therapeutic use; D019650:Hematopoietic Stem Cell Mobilization / Q000379:methods*; D006801:Humans; D007951:Leukemia, Myeloid / Q000209:etiology; D011994:Recombinant Proteins; D012306:Risk; D013997:Time Factors; D014019:Tissue Donors
D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; D000069585:Filgrastim